These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32876521)

  • 1. Evaluation of covalent binding of flutamide and its risk assessment using
    Kakutani N; Iwai T; Ohno Y; Kobayashi S; Nomura Y
    Xenobiotica; 2021 Jan; 51(1):88-94. PubMed ID: 32876521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel glutathione conjugate of flutamide in incubations with human liver microsomes.
    Kang P; Dalvie D; Smith E; Zhou S; Deese A
    Drug Metab Dispos; 2007 Jul; 35(7):1081-8. PubMed ID: 17403914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel risk assessment of reactive metabolites from discovery to clinical stage.
    Kakutani N; Nanayama T; Nomura Y
    J Toxicol Sci; 2019; 44(3):201-211. PubMed ID: 30842372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and hepatic toxicity of flutamide in cytochrome P450 1A2 knockout SV129 mice.
    Matsuzaki Y; Nagai D; Ichimura E; Goda R; Tomura A; Doi M; Nishikawa K
    J Gastroenterol; 2006 Mar; 41(3):231-9. PubMed ID: 16699857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flutamide metabolism in four different species in vitro and identification of flutamide metabolites in human patient urine by high performance liquid chromatography/tandem mass spectrometry.
    Tevell A; Lennernäs H; Jönsson M; Norlin M; Lennernäs B; Bondesson U; Hedeland M
    Drug Metab Dispos; 2006 Jun; 34(6):984-92. PubMed ID: 16540588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport, metabolism, and hepatotoxicity of flutamide, drug-drug interaction with acetaminophen involving phase I and phase II metabolites.
    Kostrubsky SE; Strom SC; Ellis E; Nelson SD; Mutlib AE
    Chem Res Toxicol; 2007 Oct; 20(10):1503-12. PubMed ID: 17900172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivation of flutamide metabolites by human liver microsomes.
    Kang P; Dalvie D; Smith E; Zhou S; Deese A; Nieman JA
    Drug Metab Dispos; 2008 Jul; 36(7):1425-37. PubMed ID: 18411402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism-based inhibition of CYP450: an indicator of drug-induced hepatotoxicity.
    Feng S; He X
    Curr Drug Metab; 2013 Nov; 14(9):921-45. PubMed ID: 24016115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of a new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients.
    Goda R; Nagai D; Akiyama Y; Nishikawa K; Ikemoto I; Aizawa Y; Nagata K; Yamazoe Y
    Drug Metab Dispos; 2006 May; 34(5):828-35. PubMed ID: 16507648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of reactive metabolite formation using 35S-labeled glutathione.
    Takakusa H; Masumoto H; Makino C; Okazaki O; Sudo K
    Drug Metab Pharmacokinet; 2009; 24(1):100-7. PubMed ID: 19252339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
    Berson A; Wolf C; Chachaty C; Fisch C; Fau D; Eugene D; Loeper J; Gauthier JC; Beaune P; Pompon D
    J Pharmacol Exp Ther; 1993 Apr; 265(1):366-72. PubMed ID: 8386241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress/reactive metabolite gene expression signature in rat liver detects idiosyncratic hepatotoxicants.
    Leone A; Nie A; Brandon Parker J; Sawant S; Piechta LA; Kelley MF; Mark Kao L; Jim Proctor S; Verheyen G; Johnson MD; Lord PG; McMillian MK
    Toxicol Appl Pharmacol; 2014 Mar; 275(3):189-97. PubMed ID: 24486436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy for Hepatotoxicity Prediction Induced by Drug Reactive Metabolites Using Human Liver Microsome and Online 2D-Nano-LC-MS Analysis.
    Zhuo Y; Wu JL; Yan X; Guo MQ; Liu N; Zhou H; Liu L; Li N
    Anal Chem; 2017 Dec; 89(24):13167-13175. PubMed ID: 29172493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics-on-a-chip of hepatotoxicity induced by anticancer drug flutamide and Its active metabolite hydroxyflutamide using HepG2/C3a microfluidic biochips.
    Choucha Snouber L; Bunescu A; Naudot M; Legallais C; Brochot C; Dumas ME; Elena-Herrmann B; Leclerc E
    Toxicol Sci; 2013 Mar; 132(1):8-20. PubMed ID: 22843567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of the antiandrogen flutamide in isolated rat hepatocytes.
    Fau D; Eugene D; Berson A; Letteron P; Fromenty B; Fisch C; Pessayre D
    J Pharmacol Exp Ther; 1994 Jun; 269(3):954-62. PubMed ID: 8014883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of human metabolites of the anti-cancer drug flutamide via biotransformation in Cunninghamella species.
    Amadio J; Murphy CD
    Biotechnol Lett; 2011 Feb; 33(2):321-6. PubMed ID: 20931353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suspected cross-hepatotoxicity of flutamide and cyproterone acetate.
    Miquel M; Soler A; Vaqué A; Ojanguren I; Costa J; Planas R
    Liver Int; 2007 Oct; 27(8):1144-7. PubMed ID: 17845544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sex-difference on flutamide metabolism in rat liver microsomal cytochrome P450 1A2].
    Wang HX; Li D; Xu CJ; Liu X
    Yao Xue Xue Bao; 2002 Aug; 37(8):608-10. PubMed ID: 12567773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development.
    Thompson RA; Isin EM; Li Y; Weaver R; Weidolf L; Wilson I; Claesson A; Page K; Dolgos H; Kenna JG
    Chem Biol Interact; 2011 Jun; 192(1-2):65-71. PubMed ID: 21074519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flutamide-induced acute hepatitis: investigation on the role of immunoallergic mechanisms.
    Pontiroli L; Sartori M; Pittau S; Morelli S; Boldorini R; Albano E
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):310-4. PubMed ID: 9759603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.